Loading organizations...
§ Private Profile · Seattle, WA, USA
Nufabrx manufactures pillowcases designed to actively fight blemishes while its users are asleep.
Nufabrx develops and manufactures medicated infused fabrics designed to deliver therapeutic benefits directly through clothing. The company focuses on disrupting traditional drug delivery methods by embedding active ingredients into textile fibers. This technology allows for sustained relief of symptoms, such as pain, directly at the source.
Nufabrx's product range includes apparel engineered for pain relief and specialized pillowcases crafted from natural bamboo fibers, which are designed to actively combat blemishes during sleep. Their proprietary infusion process integrates clinically proven ingredients like capsaicin into each fabric strand, aiming for effective and safe delivery.
Nufabrx has raised $15.0M across 2 funding rounds.
Nufabrx infuses clinically proven, safe, and effective compounds, such as capsaicin, directly into each strand of its fabrics to deliver therapeutic benefits.
Nufabrx disrupts traditional drug delivery by embedding medicine directly into clothing, allowing for sustained and localized symptom relief through wearable textiles.
Nufabrx was acquired by Tallayne, indicating a change in its corporate ownership structure.
Nufabrx infuses clinically proven, safe, and effective compounds, such as capsaicin, directly into each strand of its fabrics to deliver therapeutic benefits.
Nufabrx disrupts traditional drug delivery by embedding medicine directly into clothing, allowing for sustained and localized symptom relief through wearable textiles.
Nufabrx was acquired by Tallayne, indicating a change in its corporate ownership structure.
Nufabrx specializes in the development of textile-based drug delivery systems, integrating medicinal compounds directly into fabric. This approach positions the company within the biotechnology research sector, aiming to provide symptomatic relief through wearable technology. Their core innovation involves a proprietary method for infusing active pharmaceutical ingredients into clothing fibers, enabling continuous and localized therapeutic effects.
The company's product portfolio includes various applications, such as pain-relieving apparel. These garments are engineered to deliver medication directly to the skin, offering an an alternative to topical creams or oral medications for managing discomfort. By embedding active ingredients into the fabric, Nufabrx seeks to provide all-day symptom relief for users.
In addition to pain management, Nufabrx has developed specialized personal care products. An example is their line of pillowcases, which are designed to address blemishes. These pillowcases are hand-crafted from natural bamboo fibers and incorporate active ingredients intended to fight skin imperfections while the user sleeps.
Nufabrx's technology is built upon the infusion of clinically proven, safe, and effective compounds, such as capsaicin, into each strand of fabric. This method ensures that the therapeutic agents are consistently released when the clothing is worn, providing targeted benefits. The company aims to redefine how medicine is delivered by making it an integral part of everyday wear.
Nufabrx has raised $15.0M across 2 funding rounds. Most recently, it raised $5.0M Venture Round in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 3, 2026 | $5M Venture Round | Meltzer Capital | — | Announced |
| Oct 14, 2021 | $10M Series A | — | Charlotte Angel Fund, DBR Investments, Fields Texas, NC State University | Announced |